Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Bile Reflux
Total 0 results
Nothing found
Sponsors and Collaborators
Korean Society of Spine Surgery
GFI
Apollo Neuroscience, Inc.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
RMIT University, Melbourne, Australia
Alma Lasers Inc.
Nacuity Pharmaceuticals, Inc.
Everett Meyer
Agency for Science, Technology and Research
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
iCAD
Kupfer, David J., M.D.
Neurophth Therapeutics Inc
Mª Victoria Maestre Sanchez
Hospital Durand, Argentina
Eurofins Genoma
ASST Cremona, Cremona
Aptis Medical
Hospital ASEPEYO Sant Cugat
View Full List
Medical Conditions
Social Anxiety
Optimys Femoral Stem
Accuracy and Precision of Noninvasive Measurement
LOW OVARIAN RESPONSE
STEMI - ST-segment Elevation Myocardial Infarction
Anaplastic Large-cell Lymphoma
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
Artificial Pancreas
Renal Function Disorder
Surgical Patient
Hospital Acquired Pressure Ulcer
Anatomic Stage 2A Breast Cancer AJCC v8
Dislocation, Shoulder
Age-related Hearing Loss
Sporadic
Decay
PD-1 Refractory Advanced Melanoma
Neck Mass
Post Covid-19 Condition
Extraarticular Fracture
View Full List
Drug Interventions
Standard of care (SOC) for COVID-19
Camptosar
TPN-101
Fospropofol disodium, propofol
Desvenlafaxine
MLN2480
Capecitabine and IMRT (if randomized to this arm)
Anticholinergic
PD-1/PD-L1 inhibitor
Olopatadine
OnabotulinumtoxinA
Intravenous deferiprone
GLPG1837 multiple ascending doses
Letrozole
THC
Midazolam
RDX227675
Oxycodone/acetaminophen 5/325 mg
Capecitabine/cisplatin
Intravenous Formulation of PD-0332991
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Egypt
Contract Research Organizations in Hong Kong
Contract Research Organizations in Iran
Contract Research Organizations in Israel
Contract Research Organizations in Jamaica
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Madagascar
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Senegal
Contract Research Organizations in Taiwan
Contract Research Organizations in Ukraine
Contract Research Organizations in Uruguay
CRO list by country
CROs in Djibouti
SGS
All CROs in Djibouti
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe